Format

Send to

Choose Destination
Heart Fail Clin. 2018 Jul;14(3):327-331. doi: 10.1016/j.hfc.2018.02.007.

Pulmonary Hypertension: The Role of Lung Transplantation.

Author information

1
Lung Institute, University of Arizona, Banner University Medical Center, 755 E. McDowell Road, 3rd Floor, Phoenix, AZ 85006, USA.
2
Department of Respiratory Disease, Federico II University of Naples, Naples, Italy.
3
Pulmonary and Critical Care Medicine, University of California, Los Angeles, David Geffen School of Medicine, 10833 Le Conte Avenue, Room 37-131 CHS, Box 951690, Los Angeles, CA 90095, USA.
4
Lung Institute, University of Arizona, Banner University Medical Center, 755 E. McDowell Road, 3rd Floor, Phoenix, AZ 85006, USA. Electronic address: rajeev.saggar@bannerhealth.com.

Abstract

Despite advances in targeted medical therapy, pulmonary arterial hypertension (PAH) remains a fatal disease because of progressive right ventricular dysfunction. For patients who are refractory to medical therapy, heart-lung and lung transplantation are important treatment options. Because of longer waiting time, surgical interventions including extracorporeal lung support and atrial septostomy can be used in PAH patients bridging to transplantation.

KEYWORDS:

Extracorporeal lung support; Heart-lung transplant; Idiopathic pulmonary arterial hypertension; Lung allocation score; Lung transplantation

PMID:
29966630
DOI:
10.1016/j.hfc.2018.02.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center